The European Commission on Monday said it has launched a legal action against vaccine maker AstraZeneca for failing to respect the terms of its contract with the EU.
Spokesman Stefan De Keersmaecker said, The Commission has started last Friday legal action against the company AstraZeneca on the basis of breaches of the advance purchase agreement.
He said that the reason for the legal action was that some terms of the contract have not been respected and that the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.
AstraZeneca’s contract with the European Union foresaw an initial 300 million doses for distribution among the 27 member countries, with option for a further 100 million.
But only 30 million doses were delivered in the first quarter of 2021, and the company says it can only provide 70 million in the second quarter, rather than the 180 million it had promised.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.